A number of effective maintenance medication options exist for bipolar disorder (BD) and
these are regarded as the foundation of long-term treatment in BD. However, nonadherence …

Background Long-term symptomatic status in persons with major depressive and bipolar
disorders treated clinically is not well established, although mood disorders are leading …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Background: Psilocybin, the primary psychoactive component of psychedelic 'magic
mushrooms', may have potential for treating depressive symptoms, and consequent …

About half of the patients diagnosed with bipolar disorder (BD) become non-adherent during
long-term treatment, a rate largely similar to other chronic illnesses and one that has …

Background Several medicines are prescribed for chronic disease management; however,
adherence to long-term therapy remains poor. Culture influences beliefs about medications …

Poor medication adherence is a pervasive problem that causes disability and suffering as
well as extensive financial costs among individuals with bipolar disorder (BD). Barriers to …

Purpose This study was carried out to evaluate factors resulting in medication
nonadherence within 6 months before admission to the psychiatric service of our hospital for …

Objective: To characterize the feasibility and safety of a wireless networked system
incorporating physiologic assessments and direct confirmation of digital tablet ingestions in …

Background Approximately half of service users with schizophrenia or bipolar disorder do
not fully follow treatment recommendations. Studies of adherence have not adequately …